AI-generated summary
The authors studied 20 melasma patients treated with a low-dose 1064-nm Q-switched Nd:YAG laser over five sessions one week apart, assessing 40 sites with non-invasive skin measurements. They report increased skin lightness and a significant decrease in melanin index, and conclude the laser appears to be an effective treatment. The abstract notes the small sample and that results from non-invasive measurements were the main outcomes.
- Participants
- 20
- Who or what was studied
- Twenty patients with melasma, with two regions evaluated per patient (40 sites)
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- The abstract reports a small uncontrolled sample evaluated only with non-invasive measurements, and it does not describe a control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Dose, Fluence, Melanin. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.